Speech and Language Disorders Associated With 7q31 Deletions Implicating FOXP2
ABSTRACT Some 7q31 deletions encompass FOXP2, a gene long associated with speech and language disorders. Intragenic pathogenic FOXP2 variants cause FOXP2‐related speech and language disorder, which has been well characterized in the literature. Conversely, the phenotype associated with 7q31 deletions is neglected.
Lottie D. Morison+3 more
wiley +1 more source
Detecting existence of a hidden mediator between a pair of individual time series. [PDF]
Mohiuddin M+5 more
europepmc +1 more source
ABSTRACT Schizophrenia is a neurodevelopmental psychiatric disorder characterized by symptoms of psychosis, thought disorder, and flattened affect. Immune mechanisms are associated with schizophrenia, though the precise nature of this relationship (causal, correlated, consequential) and the mechanisms involved are not fully understood.
David Stacey+6 more
wiley +1 more source
Correction to "Vaccine Hesitancy or Hesitancies? A Latent Class Analysis of Pediatric Patients' Parents". [PDF]
europepmc +1 more source
Toward a Smartphone-Based and Conversational Agent-Delivered Just-in-Time Adaptive Holistic Lifestyle Intervention for Older Adults Affected by Cognitive Decline: Two-Week Proof-of-Concept Study. [PDF]
Brill E+5 more
europepmc +1 more source
ABSTRACT Investigations into the etiology and genetic basis of autism continue to drive much autism research, yet reports are emerging of this research not aligning with priorities of autistic people. Engagement of autistic people in the research process is a key way to take their perspectives on board.
Heidi Kristiina Kaljusto+2 more
wiley +1 more source
Genetics of Response to ECT, TMS, Ketamine and Esketamine
ABSTRACT Treatment‐resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined.
Clio E. Franklin+18 more
wiley +1 more source
Trusted Professional Multi-Agency Transitions for Young People Facing Multiple Disadvantage - Learning from Co-Production by a Third Sector Partner in the Plymouth Alliance, UK. [PDF]
Doyle G+4 more
europepmc +1 more source
ABSTRACT Rare diseases impact approximately 1 in 10 people worldwide, and yet, less than 5% of all rare diseases currently have an approved treatment option available. This is due to many challenges unique to rare diseases, including small, diverse patient populations, the cost of drug development that is not proportionate to the number of patients who
Caleb P. Bupp+7 more
wiley +1 more source
Correction: Developing Disability-Focused Pre-Health and Health Professions Curricula. [PDF]
Bracken RC+7 more
europepmc +1 more source